Scientists and physicians needed a better model to understand neurofibromatosis in order to help affected children. A groundbreaking research partnership at UW–Madison is showing the way.
This summer, in a unique collaboration, a team from the University of Wisconsin–Madison recovered wreckage and possible human remains from a site in France where an American pilot crashed during World War II.
The study provided a level of detail not available even five years ago. Improved technology cut the time to analyze all the proteins in a yeast sample from four hours to one hour.
A Madison lab is using the university's quick response manufacturing techniques to bring products to market more quickly and improve profits.
"We get two for the price of one," says researcher Shannon Stahl, "and we can save half a volt ... In a fuel cell, that is significant saving of energy."
The company makes cutting-edge products based on discoveries by three UW scientists for delivering DNA and RNA into cells.
Lynx Biosciences is developing technology to choose the drug most likely to benefit a blood cancer patient by analyzing how the tumor cells respond.
Unlike many young biotech spinoffs, Fritz Schomburg's company — Lytic — earns its income not from federal research grants, but from shipping product.
As biological technologies advance, UW–Madison is preparing adult students to capitalize on that trend through a career-changing master’s degree in biotechnology.
Researchers at Simon Gilroy's lab in the Department of Botany at the University of Wisconsin–Madison expect to greet a truck this afternoon that is carrying small containers holding more than 1,000 frozen plants that germinated and grew aboard the International Space Station.
Scientists have found how the electric fish evolved its jolt.